Immune Design Corp IPO Research Information

Immune Design Corp IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Immune Design Corp, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Immune Design Corp	IMDZ - NASDAQ	$12.00-$14.00	$12.00	$12.15	5 million	7/24/2014
Underwriter(s): Jefferies, Leerink Partners, Wells Fargo Securities
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2014-06-24 Amendment 2014-06-30 Terms Added 2014-07-14

Immune Design Corp Quote & Chart - Click for current quote - IMDZ

About Immune Design Corp (adapted from Immune Design Corp prospectus):
They are a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.

This description is adapted from Immune Design Corp prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Immune Design Corp "IMDZ" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.